The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients

被引：20

作者：

Ortega Gonzalez, Enrique ^{[1
]}

Boix, Vicente ^{[2
]}

Garcia Deltoro, Miguel ^{[1
]}

Lopez Aldeguer, Jose ^{[3
]}

Portilla, Joaquin ^{[4
]}

Montero, Marta ^{[3
]}

Ballester Belda, Emilio ^{[1
]}

Abril, Vicente ^{[1
]}

Gutierrez, Felix ^{[5
]}

Minguez, Carlos ^{[6
]}

Galindo, Josefa ^{[7
]}

Benirto, Concepcion ^{[8
]}

Garcia Rodriguez, Magdalena ^{[1
]}

Giner, Livia ^{[4
]}

Rubio, Puricacion ^{[1
]}

Uso, Jorge ^{[6
]}

Llerena, Giovanna ^{[1
]}

机构：

[1] Univ Valencia, Gen Hosp, Infect Dis Unit, Valencia, Spain

[2] Univ Alicante, Gen Hosp, Infect Dis Unit, Valencia, Spain

[3] Univ Valencia, Hosp La Fe, Infect Dis Unit, Valencia, Spain

[4] Univ Alicante, Gen Hosp, Infect Dis Unit, E-03080 Alicante, Spain

[5] Univ Elche, Gen Hosp, Infect Dis Unit, Alicante, Spain

[6] Univ Castellon, Gen Hosp, Infect Dis Unit, Castellon De La Plana, Spain

[7] Univ Valencia, Hosp Clin, Infect Dis Unit, Valencia, Spain

[8] Hosp Gen Marina Baja, Infect Dis Unit, Alicante, Spain

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2014年 / 17卷

关键词：

D O I：

10.7448/IAS.17.4.19643

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P111

引用

页码：100 / 100

页数：1

共 50 条

[21] PLASMA CELLS ARE PRESENT IN LIVER BIOPSIES OF HIV/HCV CO-INFECTED PATIENTS
Vachon, Marie-Louise C.
Branch, Andrea D.
Dieterich, Douglas T.
Fiel, M. Isabel
[J]. HEPATOLOGY, 2010, 52 (04) : 1230A - 1230A
[22] Severity of liver disease in Hispanic patients co-infected with HCV-HIV.
Rodriguez-Torres, M
Rodriguez, JF
[J]. HEPATOLOGY, 2001, 34 (04) : 231A - 231A
[23] Influence of interferon (IFN)-based therapy on liver fibrosis progression (LFP) in HIV/HCV co-infected patients
Benhamou, Yves
Valentin, Marc Antoine
Dominguez, Stephanie
Varastet, Marina
Zin, Adeline
Katlama, Christine
Poynard, Thierry
[J]. HEPATOLOGY, 2007, 46 (04) : 849A - 849A
[24] Usefulness of the AST to platelet ratio index (APRI) for predicting liver fibrosis in HIV/HCV co-infected patients
Carvalho Filho, R. J.
Narciso, J. L.
Schiavon, L. L.
Sampaiol, J. P.
Lanzoni, V. P.
Ferraz, M. L. G.
Silva, A. E. B.
[J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S189 - S190
[25] Sofosbuvir and ledipasvir for HIV/HCV co-infected patients
Rosenthal, Elana S.
Kottilil, Shyam
Polis, Michael A.
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (05) : 743 - 749
[26] Survival in HCV/HIV co-infected patients.
Hassanein, TI
Aronson, N
Oliver, DL
Barber, E
Hilsabeck, RC
Chatfield, E
Stewart, M
Mathews, C
[J]. HEPATOLOGY, 2001, 34 (04) : 232A - 232A
[27] The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients
Carrieri, Maria Patrizia
Protopopescu, Camelia
Marcellin, Fabienne
Wittkop, Linda
Lacombe, Karine
Esterle, Laure
Sogni, Philippe
Salmon-Ceron, Dominique
[J]. JOURNAL OF HEPATOLOGY, 2018, 68 (04) : 845 - 847
[28] HLA FOOTPRINTS IN HIV/HCV CO-INFECTED PATIENTS
Dold, L.
Althausen, E.
Schwarze-Zander, C.
Boesecke, C.
Wasmuth, J. -C.
Strassburg, C. P.
Rockstroh, J. K.
Spengler, U.
[J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S149 - S149
[29] Assessment of liver fibrosis in co-infected patients
Kelleher, TB
Afdhal, N
[J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S126 - S131
[30] Metabolic Syndrome in HIV/HCV Co-infected Patients
Lauren F. Collins
Ruth O. Adekunle
Emily J. Cartwright
[J]. Current Treatment Options in Infectious Diseases, 2019, 11 : 351 - 371

← 1 2 3 4 5 →